Euroscreen Receives Key Patent for Purinergic Receptor
Euroscreen SA today announced that it was awarded a US patent that covers the use of a G-protein-coupled receptor (GPCR) known as the human P2Y11 receptor. Euroscreen’s patent protects the sequence of P2Y11 receptor and research tools comprising this sequence. 2006-05-16

Robots Manipulating Animal Behaviour
Researchers recently succeeded in controlling cockroaches with tiny mobile robots. The results hint at a future where we can interact and communicate with many different kinds of animal. 2006-05-10

Cerealtop™: a Top Belgian Invention
Cerealtop™ is a box lid made up of two parts and sealed with a handy dispenser flap. Made from food-safe plastic, Cerealtop™ has a clever slider system that means it can be adjusted to suit just about any box. 2006-04-29 (Friend of PRWeb: 5)

The Online Markets of IHB and Fordaq are Now Interconnected
The online markets of IHB (ihb.de) and Fordaq (fordaq.com) are now interconnected allowing access to the largest online market for the wood industry worldwide 2006-03-25

Euroscreen Appoints Jean Combalbert, Ph.D., as CEO
Euroscreen SA announced the appointment of Jean Combalbert, Ph.D. to the position of President & Chief Executive Officer. Dr. Combalbert joins Euroscreen with more than 15 years experience in pharmaceutical and biotech companies. 2006-03-17

New Language Transforms Business Reporting
By smartly tagging data and content, an XML family offshoot is revolutionising business reports. It is now used extensively across Europe and is fast becoming a mandatory standard for financial and business reports worldwide. 2006-03-17

Institute Pasteur Korea and Euroscreen Form Strategic Alliance for GPCR Drug Discovery
The Institute Pasteur Korea (IPK) and Euroscreen s.a. today announced a partnership to perform screening of G protein coupled receptors using internalization assays. The development at the Institute Pasteur Korea of a visual-based High Throughput Screening platform offers unique opportunities for the identification of drug candidates activating receptor internalization while Euroscreen’s receptor cell lines and GPCR library compounds will provide the initial direction and components for this drug discovery collaboration. 2006-02-27

Getting Fired is Now the Beginning of the Beginning
The word fired today is too common on the news, big companies are under pressure to become leaner and meaner in face of tough competition. CvTips.com provides the unemployed with tips for developing job search skills. 2006-01-27

New Gay Market Research Adds Up the Buying Power of Pink Pounds - All 70 Billion of Them
For the first time new research, released today in London, reveals just how much the UK gay market is actually worth. Britain's 3 million gay and lesbian citizens last year earned over 70 billion pounds. This income - along with fewer children in gay households - leads to higher disposable gay incomes that are now attracting the marketing attention of some of the UK's biggest companies. 2006-01-22 (Friend of PRWeb: 3)

New Web Store Offers Authentic Designer Handbags at Low Prices: JP Tod's, Fendi, Gucci, Prada, Marc Jacobs, and More
Genuine Designer Bags is a new web store that offers authentic hand bags and purses from such brands as JP Tod's, Fendi, Gucci, Prada and Marc Jacobs at very low prices. All items are guaranteed authentic and new. 2006-01-16

UK Gays and Lesbians Unable to Reveal Sexuality at Work
Gay at home, but not at work. In the UK gay people recently started visiting their local registry offices to say 'I do'. But when it comes to being honest to their co-workers about being gay, up to half say 'I can't'. New research shows why. 2006-01-13 (Friend of PRWeb: 3)

PharmaDesign and Euroscreen Form Strategic Alliance for GPCR Deorphanization
PharmaDesign, Inc. and Euroscreen s.a. today announced a partnership to identify novel natural peptide ligands for orphan human G protein coupled receptors. PharmaDesign’s proprietary peptide library offers novel opportunities for identification of novel natural ligands while Euroscreen’s expertise in GPCR target discovery, functional screening of orphan receptors and pharmacological characterization will provide rapid screening of PharmaDesign’s Library and subsequent target validation. The partnership will provide novel Targets for partnering with shared income for the companies. 2006-01-05

Three Disaster Sites to Commence Operation
A Belgian company 444.Net N.V. www.444.net engaged in the business of on-line shopping comparison and internet searching service shall open three (3) sites www.tsunami.ws , www.hurricaneforum.info , www.earthquakeonline.info that would cater to disaster circumstances such as server disaster and other disasters, whether natural or man-made, which threatens or have compromised vital data and archival materials. 2005-12-16 (Friend of PRWeb: 15)

We Need Moderators
Do you want to do something valuable to help the victims of natural disasters without leaving your comfy chair? 2005-12-16 (Friend of PRWeb: 15)

The World’s First Forum for Advanced Infection Prevention Provided by Nonwovens
EDANA pioneers the first ever conference dedicated to the issue of infection prevention and the solutions that the nonwovens industry can bring. Taking place in Prague on Monday, 20th to Tuesday, 21st March 2006, this global conference, IN CONTROL!, is supported by healthcare institutions, associations and industry. 2005-12-14

European Patent Awarded for CCR5 Chemokine Receptor, a Crucial Target for Novel AIDS Therapy
ICOS extends the Joint patent estate with Euroscreen in Europe 2005-11-15

Euroscreen Strengthens its Patent Position in the Field of Inflammatory Targets
European patent awarded for uses of Chemerin receptor and its natural ligand, both implicated in the control of physiological and pathological inflammatory reactions 2005-11-09

Euroscreen Awarded US Patent on P2Y13 (GPR86) Receptor
Euroscreen SA, today announced the issuance of a US patent which covers the use of a human G-protein-coupled receptor (GPCR) known as the human P2Y13. Euroscreen's patent protects any screening process using this receptor in order to find compounds that modulate its activity, and thus may have pharmaceutical potential. 2005-09-20

UN Reform: Democratization Necessary - For a Parliamentary Assembly at the UN
At the occassion of the opening of the 60th United Nations General Assembly in New York Members of the European Parliament in Brussels have called for democratizing the UN. 2005-09-13

Euroscreen Awarded US Patent Covering Mutant Polypeptides of SHIP2, an Emerging Target for the Treatment of Type 2 Diabetes Mellitus
Euroscreen SA, today announced the issuance of a US patent which protects specific mutants affected in the catalytic site of the human SHIP2 protein. These are mutant proteins of SH2 domain containing inositolphosphate5-Phosphatase type2 (SHIP2). 2005-08-31